Adolescents and young adults (AYA) with acute lymphoblastic leukemia / 대한내과학회지
Korean Journal of Medicine
;
: 459-463, 2007.
Article
in Korean
| WPRIM
| ID: wpr-107840
ABSTRACT
Adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) constitute a distinct population from children and older adults. However, AYA represent a minority of patients enrolled onto either adult or pediatric clinical trials. As a result, little information is available regarding complete remission (CR), event-free survival (EFS) and overall survival (OS) rates for this age group, and the appropriate treatment regimen for this group of patients remains elusive. A systematic review of all published clinical trials, which provide data on treatment and outcome of AYA with ALL, has been summarized in an effort to determine whether they should be treated on pediatric or adult protocols. AYA with ALL have far superior outcomes when treated on more intensive pediatric regimens and are required specific collaborative trials in order to optimize and improved outcomes.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Disease-Free Survival
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Type of study:
Practice guideline
Limits:
Adolescent
/
Adult
/
Child
/
Humans
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS